A 1 Year Observational Study of the Use of Etanercept in Routine German Clinical Practice to Treat Rheumatoid Arthritis Patients: a Health Economic, Safety and Effectiveness Evaluation
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer; Wyeth
- 10 Jun 2017 Biomarkers information updated
- 30 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2013 Planned End Date changed from 1 Apr 2013 to 1 May 2013 as reported by ClinicalTrials.gov.